DexCom
DXCM
DXCM
940 hedge funds and large institutions have $27.7B invested in DexCom in 2024 Q4 according to their latest regulatory filings, with 189 funds opening new positions, 329 increasing their positions, 332 reducing their positions, and 115 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.09% more ownership
Funds ownership: 89.17% → 91.26% (+2.1%)
1% less repeat investments, than reductions
Existing positions increased: 329 | Existing positions reduced: 332
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Holders
940
Holding in Top 10
7
Calls
$728M
Puts
$499M
Top Buyers
| 1 | +$356M | |
| 2 | +$235M | |
| 3 | +$213M | |
| 4 |
Morgan Stanley
New York
|
+$129M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$124M |
Top Sellers
| 1 | -$441M | |
| 2 | -$294M | |
| 3 | -$278M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$124M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$99.2M |